These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 18768228

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy.
    Baumann P, Nyman J, Hoyer M, Wennberg B, Gagliardi G, Lax I, Drugge N, Ekberg L, Friesland S, Johansson KA, Lund JA, Morhed E, Nilsson K, Levin N, Paludan M, Sederholm C, Traberg A, Wittgren L, Lewensohn R.
    J Clin Oncol; 2009 Jul 10; 27(20):3290-6. PubMed ID: 19414667
    [Abstract] [Full Text] [Related]

  • 3. Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial.
    Ricardi U, Filippi AR, Guarneri A, Giglioli FR, Ciammella P, Franco P, Mantovani C, Borasio P, Scagliotti GV, Ragona R.
    Lung Cancer; 2010 Apr 10; 68(1):72-7. PubMed ID: 19556022
    [Abstract] [Full Text] [Related]

  • 4. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer.
    Zimmermann FB, Geinitz H, Schill S, Grosu A, Schratzenstaller U, Molls M, Jeremic B.
    Lung Cancer; 2005 Apr 10; 48(1):107-14. PubMed ID: 15777977
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
    Salazar OM, Sandhu TS, Lattin PB, Chang JH, Lee CK, Groshko GA, Lattin CJ.
    Int J Radiat Oncol Biol Phys; 2008 Nov 01; 72(3):707-15. PubMed ID: 18455322
    [Abstract] [Full Text] [Related]

  • 7. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer.
    Xia T, Li H, Sun Q, Wang Y, Fan N, Yu Y, Li P, Chang JY.
    Int J Radiat Oncol Biol Phys; 2006 Sep 01; 66(1):117-25. PubMed ID: 16765528
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: clinical outcome.
    van der Voort van Zyp NC, Prévost JB, Hoogeman MS, Praag J, van der Holt B, Levendag PC, van Klaveren RJ, Pattynama P, Nuyttens JJ.
    Radiother Oncol; 2009 Jun 01; 91(3):296-300. PubMed ID: 19297048
    [Abstract] [Full Text] [Related]

  • 10. Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation.
    Hodge W, Tomé WA, Jaradat HA, Orton NP, Khuntia D, Traynor A, Weigel T, Mehta MP.
    Acta Oncol; 2006 Jun 01; 45(7):890-6. PubMed ID: 16982555
    [Abstract] [Full Text] [Related]

  • 11. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03.
    Hartsell WF, Scott CB, Dundas GS, Mohiuddin M, Meredith RF, Rubin P, Weigensberg IJ.
    Am J Clin Oncol; 2007 Aug 01; 30(4):368-76. PubMed ID: 17762437
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients.
    Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):186-96. PubMed ID: 15337555
    [Abstract] [Full Text] [Related]

  • 14. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer.
    Hiraoka M, Matsuo Y, Nagata Y.
    Cancer Radiother; 2007 Sep 01; 11(1-2):32-5. PubMed ID: 17158081
    [Abstract] [Full Text] [Related]

  • 15. Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control.
    Videtic GM, Stephans K, Reddy C, Gajdos S, Kolar M, Clouser E, Djemil T.
    Int J Radiat Oncol Biol Phys; 2010 Jun 01; 77(2):344-9. PubMed ID: 19765913
    [Abstract] [Full Text] [Related]

  • 16. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study.
    Hata M, Tokuuye K, Kagei K, Sugahara S, Nakayama H, Fukumitsu N, Hashimoto T, Mizumoto M, Ohara K, Akine Y.
    Int J Radiat Oncol Biol Phys; 2007 Jul 01; 68(3):786-93. PubMed ID: 17379439
    [Abstract] [Full Text] [Related]

  • 17. Stage I nonsmall cell lung cancer in patients aged > or =75 years: outcomes after stereotactic radiotherapy.
    Haasbeek CJ, Lagerwaard FJ, Antonisse ME, Slotman BJ, Senan S.
    Cancer; 2010 Jan 15; 116(2):406-14. PubMed ID: 19950125
    [Abstract] [Full Text] [Related]

  • 18. Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: long-term results and efficacy of adjuvant chemotherapy.
    Chen Y, Guo W, Lu Y, Zou B.
    Radiother Oncol; 2008 Sep 15; 88(3):351-8. PubMed ID: 18722684
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of stereotactic body radiotherapy in the treatment of inoperable early-stage lung cancer.
    Scorsetti M, Navarria P, Facoetti A, Lattuada P, Urso G, Mirandola A, Ferraroli GM, Alloisio M, Ravasi G.
    Anticancer Res; 2007 Sep 15; 27(5B):3615-9. PubMed ID: 17972525
    [Abstract] [Full Text] [Related]

  • 20. Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas.
    Fukumoto S, Shirato H, Shimzu S, Ogura S, Onimaru R, Kitamura K, Yamazaki K, Miyasaka K, Nishimura M, Dosaka-Akita H.
    Cancer; 2002 Oct 01; 95(7):1546-53. PubMed ID: 12237924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.